US pharma executives condemn judge’s ruling to suspend abortion drug approval
美国药企高管谴责法官暂停批准堕胎药物的裁决

More than 400 industry figures warn Texas decision would put industry innovation at risk
400多名医药和生物科技行业人士警告称，得克萨斯州的决定将危及行业创新。